Chevron, Occidental Petroleum, BHP and Bethel Lands all invested in a round that will fund further testing of Carbon Enginnering's carbon capture technology.

Pharmaceutical firm Pfizer has acquired a 15% stake in the gene therapy developer along with an exclusive option to fully buy the Novartis-backed company.

The communication software developer boosted its total funding to $91m in a round that included Anschutz Investment Company.

The data centre technology developer will put the proceeds from the CUI-led round into its marketing and research and development activities.

Alex Tepper has departed from a managing director position at General Electric's corporate VC unit to take a senior managing director role at startup studio Human Ventures.

The former head of Johnson & Johnson's JLabs@TMC incubator has been appointed director of Texas Medical Center's TMC Innovation Institute.

Busy Burr, a founding partner of Humana Health Ventures who featured on GCV’s 2017 and 2018 Powerlists, was named a director at Mr Cooper at the end of February.

The industry-focused VC vehicle is targeting $10m to make seed investments in companies including spinouts across technologies including robotics, internet-of-things and electronics.

CapitalG-backed UiPath is in the process of raising $400m in a round that will be led by an unnamed public institutional investor at a $7bn valuation.

Based on Stanford research, Surrozen is working on regenerative treatments for a wide range of conditions, with a first focus on liver disease.